SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001213900-21-067870
Filing Date
2021-12-29
Accepted
2021-12-29 14:26:59
Documents
1
Period of Report
2021-09-30
Effectiveness Date
2021-12-29

Document Format Files

Seq Description Document Type Size
1 NOTIFICATION OF LATE FILING ea153194-nt10k_rasnathera.htm NT 10-K 17302
  Complete submission text file 0001213900-21-067870.txt   18458
Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0930
Type: NT 10-K | Act: 34 | File No.: 333-191083 | Film No.: 211528413
SIC: 2834 Pharmaceutical Preparations